Financial News
All News about Y-Mabs Therapeutics Inc
![](https://mms.businesswire.com/media/20230201006121/en/774509/22/new_KM_logo.jpg)
![](https://mms.businesswire.com/media/20230130005005/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3015.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Y-mAbs Therapeutics
January 27, 2023
Via Benzinga
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://mms.businesswire.com/media/20230127005434/en/805463/22/business_Wire_Robbins_LLP.jpg)
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
Via Benzinga
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://mms.businesswire.com/media/20230126005343/en/478343/5/GPM_Logo_Colo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.marketbeat.com/logos/articles/small_stock-image_180756848_S.jpg)
![](https://mms.businesswire.com/media/20230124006140/en/1510725/22/Latest_KSF_SEC.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230124005458/en/478343/5/GPM_Logo_Colo.jpg)
![](https://mms.businesswire.com/media/20230123005679/en/1138077/5/RGRD_Logo_BusinessWire.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20230123005259/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://mms.businesswire.com/media/20230120005484/en/805463/22/business_Wire_Robbins_LLP.jpg)
![](https://mms.businesswire.com/media/20230120005040/en/478343/5/GPM_Logo_Colo.jpg)
![](https://mms.businesswire.com/media/20230119005813/en/538768/22/BES_Mark.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230119005928/en/774509/22/new_KM_logo.jpg)
![](https://mms.businesswire.com/media/20230119005882/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
![](https://mms.businesswire.com/media/20230119005752/en/1138077/5/RGRD_Logo_BusinessWire.jpg)
![](https://mms.businesswire.com/media/20230119005700/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://mms.businesswire.com/media/20230119005289/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20230118006029/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/05/ymab_logo_light__885b7e33e35f9f1e896a6280a018d780.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.